ArticleBritish journal of pharmacology2017

Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection.

Zhi-Feng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.